GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.90 $2.80 Tuesday, 16th Apr 2024 CGEN stock ended at $2.03. This is 3.57% more than the trading day before Monday, 15th Apr 2024. During the day the stock fluctuated 7.89% from a day low at $1.90 to a day high of $2.05.
90 days $1.80 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
2024-04-16 $1.96 $2.05 $1.90 $2.03 451 043
2024-04-15 $2.11 $2.19 $1.94 $1.96 749 027
2024-04-12 $2.23 $2.25 $2.09 $2.13 388 381
2024-04-11 $2.25 $2.27 $2.20 $2.26 244 600
2024-04-10 $2.31 $2.33 $2.23 $2.26 278 734
2024-04-09 $2.34 $2.40 $2.33 $2.36 152 036
2024-04-08 $2.47 $2.47 $2.33 $2.33 194 450
2024-04-05 $2.34 $2.51 $2.32 $2.42 365 001
2024-04-04 $2.38 $2.47 $2.32 $2.32 321 989
2024-04-03 $2.36 $2.44 $2.34 $2.43 145 597
2024-04-02 $2.43 $2.43 $2.30 $2.34 346 760
2024-04-01 $2.56 $2.57 $2.45 $2.47 241 550
2024-03-28 $2.54 $2.63 $2.50 $2.58 285 076
2024-03-27 $2.49 $2.58 $2.45 $2.54 309 713
2024-03-26 $2.54 $2.56 $2.44 $2.50 214 982
2024-03-25 $2.59 $2.67 $2.51 $2.53 294 037
2024-03-22 $2.66 $2.67 $2.55 $2.64 232 393
2024-03-21 $2.70 $2.75 $2.66 $2.67 231 284
2024-03-20 $2.61 $2.71 $2.50 $2.69 351 948
2024-03-19 $2.61 $2.67 $2.55 $2.58 400 506
2024-03-18 $2.76 $2.80 $2.66 $2.67 323 257
2024-03-15 $2.66 $2.73 $2.66 $2.73 218 815
2024-03-14 $2.77 $2.80 $2.63 $2.68 339 815
2024-03-13 $2.83 $2.90 $2.74 $2.81 369 067
2024-03-12 $2.78 $2.87 $2.72 $2.80 332 890
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT